More than 8,000 allergists and immunologists from around the world gathered in London this summer during the annual congress of the European Academy of Allergology and Clinical Immunology (EAACI). These experts talked about new advances in immunotherapy and vaccine candidates for a group of diseases that affect one out of every four individuals. However, the best strategy to combat asthma, rhinitis and eczema remains prevention

JORDI MONTANER | AUGUST 17th, 2010